Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination
Author:
Affiliation:
1. Genentech Inc, South San Francisco, California
2. Foundation Medicine Inc, Cambridge, Massachusetts
3. Genesis Research, Hoboken, New Jersey
4. American Cancer Society Cancer Action Network, Washington, DC
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786987/sheinson_2021_oi_211077_1638456112.38515.pdf
Reference33 articles.
1. The effect of advances in lung-cancer treatment on population mortality.;Howlader;N Engl J Med,2020
2. Value of precision medicine in advanced non–small cell lung cancer: real-world outcomes associated with the use of companion diagnostics.;John;Oncologist,2020
3. Association between Medicare’s national coverage determination and utilization of next-generation sequencing.;Sheinson;JCO Oncol Pract,2021
4. Use of next-generation sequencing tests to guide cancer treatment: results from a nationally representative survey of oncologists in the United States.;Freedman;JCO Precis Oncol.,2018
5. Utilization of tumor genomics in clinical practice: an international survey among ASCO members.;Barroso-Sousa;Future Oncol,2019
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers;JAMA Network Open;2024-07-18
2. Availability and utilization of molecular testing for primary central nervous system tumors among US hospitals;Journal of Neuropathology & Experimental Neurology;2024-04-30
3. Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types;The Journal of Molecular Diagnostics;2024-04
4. Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer Treated in the US Community Setting;JCO Oncology Practice;2024-03
5. Challenges to genetic testing for germline mutations associated with breast cancer among African Americans;Cancer Treatment Reviews;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3